Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinomaL H Einhorn, B J Roth, R Ansari, et al.Investigational New Drugs|July 16, 2008
Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic diseaseI Tamaskar, T Mekhail, R Dreicer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group StudyR Dreicer, J Manola, B J Roth, et al.American Journal of Clinical Oncology|June 17, 1998
Vinblastine, ifosfamide, gallium nitrate, and filgrastim in platinum- and paclitaxel-resistant ovarian cancer: a phase II studyR Dreicer, T A Lallas, J K Joyce, et al.American Journal of Clinical Oncology|June 1, 1997
A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group studyR Dreicer, K J Propert, T Kuzel, et al.European Journal of Cancer (Oxford, England : 1990)|February 25, 2014
A 2 weeks on and 1 week off schedule of sunitinib is associated with decreased toxicity in metastatic renal cell carcinomaY G Najjar, K Mittal, P Elson, et al.Urology|February 22, 2001
Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancerP E Clark, D M Peereboom, R Dreicer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trialP J Loehrer, P Elson, R Dreicer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinomaR S Witte, P Elson, B Bono, et al.Cancer Investigation|January 1, 1997
A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancerR Dreicer, J D Kemp, L D Stegink, et al.Pageof 6